Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorYale University

About this trial

The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.

Eligibility criteria

Qualifiers

Delivery of singleton live birth (twins reduced to singleton or with vanishing twin syndrome prior to 14 weeks qualify)

Postpartum

English or Spanish speaking

Viable pregnancy 24 weeks of gestation or above (Child can be in NICU to participate)

Disqualifiers

Multifetal pregnancy (since are they at increased risk for key outcomes)

Gestational age <24 weeks;

Known major fetal anomaly in current pregnancy or stillbirth

Actively using illicit/illegal substances (such as cocaine, heroin and other types of illicit opiates such as fentanyl) as noted in delivery hospitalization notes

Trial design

Treatments tested in this trial

  • Remote Medical Model (RMM)
  • Community Health Model (CHM)
  • SoC

Treatment groups

6,030 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Yale University

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator